Collegium Pharmaceutical (COLL)
(Delayed Data from NSDQ)
$33.14 USD
+0.71 (2.19%)
Updated May 31, 2024 04:00 PM ET
After-Market: $33.13 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Brokerage Reports
Collegium Pharmaceutical, Inc. [COLL]
Reports for Purchase
Showing records 81 - 91 ( 91 total )
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Xtampza Gaining Traction; Shares at the Cusp of Value Inflection; Initiate Buy; $21 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Company: Collegium Pharmaceutical, Inc.
Industry: Medical - Drugs
Looking For Answers - Highlights from FDA Workshop on ADF Opioids
Provider: G.RESEARCH, LLC
Analyst: KEDRA K